We have a series of projects planned for 2023 which involve nude mice models with various types of cancers to be targetted with AI selected combinations of drugs. The primary purpose is to vet likely synergistically enhancing chemical pairings to destroy tumors.

June 2023: Our first experimental project of 2023 began earlier this year. We are testing the viability of Oxaliplatin in combination with Salinomycin. Both potential chemotherapies were chosen from millions of possibilities by AI as likely mutually synergistically enhancing. Both Salinomycin and Oxaliplatin are rare in that they can kill cancer stem cells (CSC's). However, Salinomycin is considerably more selective in its targetting and more lethal in general to cancer cells of all sorts. We agree with the AI: the combo should be more potent than either alone."

July update: Our lab experienced power outtage for a week after the entire city of Tulsa was without power for more than 10 days following a 100mph wind storm. For this reason we had to restart this project. More news soon!